ZA201404176B - 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives - Google Patents

2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Info

Publication number
ZA201404176B
ZA201404176B ZA2014/04176A ZA201404176A ZA201404176B ZA 201404176 B ZA201404176 B ZA 201404176B ZA 2014/04176 A ZA2014/04176 A ZA 2014/04176A ZA 201404176 A ZA201404176 A ZA 201404176A ZA 201404176 B ZA201404176 B ZA 201404176B
Authority
ZA
South Africa
Prior art keywords
oxazolidin
diyl
oxo
antibiotic derivatives
antibiotic
Prior art date
Application number
ZA2014/04176A
Other languages
English (en)
Inventor
Acklin Cornelia Zumbrum
Georg Rueedi
Jean-Philippe Surivet
Christian Hubschwerlen
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of ZA201404176B publication Critical patent/ZA201404176B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53831,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Detergent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA2014/04176A 2011-11-08 2014-06-06 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives ZA201404176B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB2011054968 2011-11-08
PCT/IB2012/056236 WO2013068948A1 (en) 2011-11-08 2012-11-07 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Publications (1)

Publication Number Publication Date
ZA201404176B true ZA201404176B (en) 2016-05-25

Family

ID=47258051

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/04176A ZA201404176B (en) 2011-11-08 2014-06-06 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives

Country Status (21)

Country Link
US (1) US9079922B2 (enExample)
EP (1) EP2776431B1 (enExample)
JP (1) JP6030146B2 (enExample)
KR (1) KR20140096337A (enExample)
AR (1) AR088691A1 (enExample)
AU (1) AU2012335207B2 (enExample)
BR (1) BR112014011064A8 (enExample)
CA (1) CA2854264A1 (enExample)
CL (1) CL2014001154A1 (enExample)
ES (1) ES2581056T3 (enExample)
HK (1) HK1202288A1 (enExample)
IL (1) IL232463A0 (enExample)
IN (1) IN2014CN04126A (enExample)
MX (1) MX344529B (enExample)
PH (1) PH12014500831A1 (enExample)
PL (1) PL2776431T3 (enExample)
RU (1) RU2616609C2 (enExample)
SG (1) SG11201401710PA (enExample)
TW (1) TWI594996B (enExample)
WO (1) WO2013068948A1 (enExample)
ZA (1) ZA201404176B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2739373C (en) 2008-10-07 2017-01-24 Christian Hubschwerlen Tricyclic oxazolidinone antibiotic compounds
HK1221459A1 (zh) 2013-04-16 2017-06-02 Idorsia Pharmaceuticals Ltd 抗菌双芳香族衍生物
AR096135A1 (es) 2013-05-02 2015-12-09 Actelion Pharmaceuticals Ltd Derivados de la quinolona
AR102256A1 (es) 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi
MA41168A (fr) 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
MA41169A (fr) * 2014-12-17 2017-10-24 Acraf Composés antibactériens à large spectre d'activité
CN109121397A (zh) 2016-02-08 2019-01-01 莱德克斯制药公共有限公司 杂环化合物,特别是2-氧代-4,4,5,5,6,6,7,7-八氢苯并噁唑衍生物以及它们作为抗菌化合物的用途
EP3414246A1 (en) * 2016-02-08 2018-12-19 Redx Pharma PLC Antibacterial compounds
GB201602235D0 (en) * 2016-02-08 2016-03-23 Redx Pharma Plc Antibacterial compounds
AU2017276627A1 (en) 2016-06-08 2018-12-20 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. New antibacterial compounds
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物
US10912780B2 (en) 2017-06-08 2021-02-09 Bugworks Research, Inc. Heterocyclic compounds useful as anti-bacterial agents and method for production thereof
ES2952989T3 (es) * 2017-11-29 2023-11-07 Bugworks Res Inc Compuestos heterocíclicos antibacterianos y su síntesis

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
HU168497B (enExample) 1972-12-18 1976-05-28
SE444566B (sv) 1977-09-20 1986-04-21 Bellon Labor Sa Roger 7-dialkylamin-6-halogen-4-oxo-1,4-dihydrokinolin-3-karboxylsyra, forfarande for framstellning derav och farmaceutiskt preparat derav
GB1598915A (en) 1977-09-20 1981-09-23 Bellon Labor Sa Roger 1,4-dihydro-quinoline-3-carboxylic acid derivatives process for their preparation and composition containing them
CS274601B2 (en) 1983-07-27 1991-09-15 Dainippon Pharmaceutical Co Method of 1,8-naphthyridine derivative production
JPS62205060A (ja) 1986-03-04 1987-09-09 Kyorin Pharmaceut Co Ltd 8位置換キノロンカルボン酸誘導体
NO871333L (no) 1986-03-31 1987-10-01 Sankyo Co Kinolin-3-karboksylsyrederivater, fremgangsmaate til fremstilling og anvendelse derav.
JP2631854B2 (ja) 1987-12-23 1997-07-16 藤本製薬株式会社 新規な1,8−ナフチリジン誘導体
DE4301246A1 (de) 1993-01-19 1994-07-21 Bayer Ag Chinolon- und Naphthyridoncarbonsäurederivate
EP1553093A1 (en) 2002-06-28 2005-07-13 Kaneka Corporation Process for preparation of optically active 1-substituted amino-2,3-epoxypropanes, intermediates for the synthesis thereof and process for preparation of the intermediates
RU2351335C2 (ru) * 2003-04-30 2009-04-10 Морфохем Акциенгезельшафт Фюр Комбинаторише Хеми Применение оксазолидинон-хинолиновых гибридных антибиотиков для лечения сибирской язвы и других инфекций
MXPA06006769A (es) * 2003-12-18 2006-12-19 Morphochem Ag Komb Chemie Antibioticos hibridos de oxazolidinona-quinolona.
EP1771456A2 (fr) 2004-07-30 2007-04-11 Palumed SA Molecules hybrides qa ou q est une aminoquinoleine et a est un residu antibiotique, leur synthese et leurs utilisations en tant qu'agent antibacterien
DE602005015341D1 (de) 2004-09-01 2009-08-20 Ubitrak Inc System zum identifizieren und zählen von spieljetons
US20090156577A1 (en) 2004-09-09 2009-06-18 Benjamin Davis 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
WO2007118130A2 (en) 2006-04-06 2007-10-18 Glaxo Group Limited Antibacterial agents
BRPI0718862B8 (pt) * 2006-11-10 2021-05-25 Actelion Pharmaceuticals Ltd composto, composição farmacêutica que o contém e uso do composto
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
CL2008001003A1 (es) * 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
US9505750B2 (en) * 2007-12-18 2016-11-29 Actelion Pharmaceuticals Ltd. 5-aminocyclylmethyl-oxazolidin-2-one derivatives
CA2713187C (en) * 2008-02-22 2016-06-07 Actelion Pharmaceuticals Ltd Oxazolidinone derivatives
CA2739373C (en) 2008-10-07 2017-01-24 Christian Hubschwerlen Tricyclic oxazolidinone antibiotic compounds
WO2010041218A2 (en) * 2008-10-10 2010-04-15 Actelion Pharmaceuticals Ltd Oxazolidinyl antibiotics
US20110195949A1 (en) * 2008-10-10 2011-08-11 Actelion Pharmaceuticals Ltd. 2-benzothiophenyl- and 2-naphthyl-oxazolidinones and their azaisostere analogues as antibacterial agents
TW201121965A (en) 2009-09-28 2011-07-01 Lg Life Sciences Ltd Use of a quinolone derivative containing 7-(4-aminomethyl-3-oxime)pyrrolidine group that is capable of inducing granulocyte colony stimulating factor for treatment of neutropenia and recovery of hematopoiesis
CN101792443A (zh) 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途

Also Published As

Publication number Publication date
MX344529B (es) 2016-12-19
US9079922B2 (en) 2015-07-14
CA2854264A1 (en) 2013-05-16
BR112014011064A8 (pt) 2017-12-26
IL232463A0 (en) 2014-06-30
TW201326166A (zh) 2013-07-01
CN103917539A (zh) 2014-07-09
PH12014500831A1 (en) 2019-08-07
SG11201401710PA (en) 2014-09-26
RU2014123109A (ru) 2015-12-20
US20150051188A1 (en) 2015-02-19
MX2014005637A (es) 2014-06-23
AR088691A1 (es) 2014-06-25
KR20140096337A (ko) 2014-08-05
CL2014001154A1 (es) 2014-09-12
BR112014011064A2 (pt) 2017-06-13
EP2776431B1 (en) 2016-05-04
AU2012335207B2 (en) 2017-05-25
JP2014532754A (ja) 2014-12-08
EP2776431A1 (en) 2014-09-17
HK1202288A1 (en) 2015-09-25
RU2616609C2 (ru) 2017-04-18
TWI594996B (zh) 2017-08-11
WO2013068948A1 (en) 2013-05-16
PL2776431T3 (pl) 2016-11-30
IN2014CN04126A (enExample) 2015-07-10
AU2012335207A1 (en) 2014-07-03
ES2581056T3 (es) 2016-08-31
JP6030146B2 (ja) 2016-11-24

Similar Documents

Publication Publication Date Title
ZA201404176B (en) 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives
SG10201601802YA (en) Dispiropyrrolidine derivatives
EP2753642B8 (en) Glp-1 derivatives
ZA201401884B (en) New dihydroquinoline-2-one derivatives
ZA201205788B (en) 1,2,4-triazine-4-amine derivatives
AP2013007043A0 (en) Novel heterocyclic derivatives
SG11201401937YA (en) New aryl-quinoline derivatives
IL247637B (en) History of heteroaryl piperidine
ZA201404074B (en) 6-difluoromethyl-5,6-dihydro-2h-[1,4]oxazin-3-amine derivatives
ZA201401852B (en) Aniline derivatives,their therapeutic application
ZA201306229B (en) Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines
ZA201302112B (en) 1,4-oxazepane derivatives
IL233001A0 (en) New iso-ergoline histories
SI2766342T1 (sl) Derivati fenil-gvanidina
ZA201308049B (en) 3-ureidoisoquinolin-8-yl derivatives
ZA201209319B (en) Cyclopropyl-indole derivatives
GB201119592D0 (en) Novel heteroaromatic Derivatives I
GB201119958D0 (en) Antibacterial derivatives
GB201119961D0 (en) Antibacterial derivatives
HK1188994A (en) Novel heterocyclic derivatives
GB201119594D0 (en) Novel heteroaromatic derivatives II
AU2011901326A0 (en) Improved lagging
HK1186730A (en) 1,4-oxazepane derivatives